EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Day-To-Day Practice of MMR and MSI Assessment in Colorectal Adenocarcinoma: What We Know and What We Still Need to Explore

Paola Parente, Federica Grillo, Alessandro Vanoli, Maria Cristina Macciomei, Maria Raffaella Ambrosio, Nunzia Scibetta, Emanuela Filippi, Ivana Cataldo, Luigi Baron, Giuseppe Ingravallo, Gerardo Cazzato, Laura Melocchi und 17 weitere

Digestive Diseases · 2023

DOI: 10.1159/000531003 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Digestive Diseases, 2023. Verfasst von Paola Parente und 28 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Pathology, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 54 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: The DNA mismatch repair (MMR) system is a highly preserved protein complex recognizing short insertions, short deletions, and single base mismatches during DNA replication and recombination. MMR protein status is identified using immunohistochemistry. Deficit in one or more MMR proteins, configuring deficient MMR status (dMMR), leads to frameshift mutations particularly clustered in microsatellite repeats. Thus, microsatellite instability (MSI) is the epiphenomenon of dMMR. In colorectal cancer (CRC), MMR/MSI status is a biomarker with prognostic and predictive value of resistance to 5-fluorouracil and response to immune checkpoint inhibitor therapy. Summary: In this Review, we describe the challenges the practicing pathologist may face in relation to the assessment of MMR/MSI status and any open issues which still need to be addressed, focusing on pre-analytic issues, pitfalls in the interpretation, and technical aspects of the different assays. Key Messages: The current methods of detecting dMMR/MSI status have been optimized for CRCs, and whether these techniques can be applied to all tumor and specimen types is still not fully understood. Following the Food and Drug Administration (FDA), tissue/site agnostic drug approval of pembrolizumab for advanced/metastatic MSI tumors, MMR/MSI status in gastrointestinal tract is a common request from the oncologist. In this setting, several issues still need to be addressed, including criteria for sample adequacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsAdenocarcinomaBrain NeoplasmsMicrosatellite InstabilityNeoplastic Syndromes, HereditaryDNA Mismatch RepairHumans

Stichwörter der Autor:innen

Colorectal cancerImmune check point inhibitorsImmunohistochemistryImmunotherapyLynchMicrosatellitesMismatch repair

Autor:innen und Institutionen

  • Unit of Pathology, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
  • Anatomic Pathology, Department of Surgical Sciences and Integrated Diagnostics, University of Genoa, Genoa, Italy.
  • Pathology Unit, Ospedale Policlinico San Martino IRCCS, Genoa, Italy.
  • Anatomic Pathology Unit, Department of Molecular Medicine, University of Pavia and Fondazione IRCCS San Matteo Hospital, Pavia, Italy.
  • Anatomia Patologica Azienda Ospedaliera San Camillo Forlanini, Rome, Italy.
  • Pathology Department, Azienda USL, Tuscany North-West, Pisa, Italy.

Zitieren

APA

Parente, P., Grillo, F., Vanoli, A., Macciomei, M. C., Ambrosio, M. R., Scibetta, N., Filippi, E., Cataldo, I., Baron, L., Ingravallo, G., Cazzato, G., Melocchi, L., Liserre, B., Giordano, C., Arborea, G., Pilozzi, E., Scapinello, A., Aquilano, M. C., Gafà, R., …, & Fassan, M. (2023). The Day-To-Day Practice of MMR and MSI Assessment in Colorectal Adenocarcinoma: What We Know and What We Still Need to Explore. Digestive Diseases. https://doi.org/10.1159/000531003

Vancouver

Parente P, Grillo F, Vanoli A, Macciomei MC, Ambrosio MR, Scibetta N, et al. The Day-To-Day Practice of MMR and MSI Assessment in Colorectal Adenocarcinoma: What We Know and What We Still Need to Explore. Digestive Diseases. 2023. doi:10.1159/000531003

BibTeX
@article{Parente2023,
  author = {Parente, Paola and Grillo, Federica and Vanoli, Alessandro and Macciomei, Maria Cristina and Ambrosio, Maria Raffaella and Scibetta, Nunzia and Filippi, Emanuela and Cataldo, Ivana and Baron, Luigi and Ingravallo, Giuseppe and Cazzato, Gerardo and Melocchi, Laura and Liserre, Barbara and Giordano, Carla and Arborea, Graziana and Pilozzi, Emanuela and Scapinello, Antonio and Aquilano, Maria Costanza and Gafà, Roberta and Battista, Serena and Dal Santo, Luca and Campora, Michela and Carbone, Francesco Giuseppe and Sartori, Chiara and Lazzi, Stefano and Hanspeter, Ester and Angerilli, Valentina and Mastracci, Luca and Fassan, Matteo},
  title = {The Day-To-Day Practice of MMR and MSI Assessment in Colorectal Adenocarcinoma: What We Know and What We Still Need to Explore},
  journal = {Digestive Diseases},
  year = {2023},
  doi = {10.1159/000531003}
}
Kostenlos starten →